Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Operating Margin %: 28.17% (As of Mar. 2026) — Near Median


SHSE:600566 Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
86 GF Score
Price ¥21.66
GF Value ¥20.89
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Hubei Jumpcan Pharmaceutical Co Operating Margin %?

Hubei Jumpcan Pharmaceutical Co SHSE:600566 -2.39% 86 Operating Margin % is 28.17% as of Mar. 2026, which is 9% above its 10-year median of 25.91. GuruFocus rates SHSE:600566 with a GF Score™ of 86/100 and a GF Value™ of ¥20.89 (Fairly Valued). The stock has 3 warning signs investors should review. Among 952 Drug Manufacturers companies, Hubei Jumpcan Pharmaceutical Co ranks better than 94.64% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Hubei Jumpcan Pharmaceutical Co's Operating Income for the three months ended in Mar. 2026 was ¥340 Mil. Hubei Jumpcan Pharmaceutical Co's Revenue for the three months ended in Mar. 2026 was ¥1,207 Mil. Therefore, Hubei Jumpcan Pharmaceutical Co's Operating Margin % for the quarter that ended in Mar. 2026 was 28.17%.

Good Sign:

Hubei Jumpcan Pharmaceutical Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Hubei Jumpcan Pharmaceutical Co's Operating Margin % or its related term are showing as below:

SHSE:600566' s Operating Margin % Range Over the Past 10 Years
Min: 22.15   Med: 25.91   Max: 30.89
Current: 30.89


SHSE:600566's Operating Margin % is ranked better than
94.64% of 952 companies
in the Drug Manufacturers industry
Industry Median: 7.58 vs SHSE:600566: 30.89

Hubei Jumpcan Pharmaceutical Co's 5-Year Average Operating Margin % Growth Rate was 7.40% per year.

Hubei Jumpcan Pharmaceutical Co's Operating Income for the three months ended in Mar. 2026 was ¥340 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1,823 Mil.


Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Hubei Jumpcan Pharmaceutical Co Operating Margin % Related Terms


Hubei Jumpcan Pharmaceutical Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Jumpcan Pharmaceutical Co Operating Margin % Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.15 25.68 30.05 30.18 30.19

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.86 21.60 29.25 38.15 28.17

SHSE:600566 vs ZTS, UTHR: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Jumpcan Pharmaceutical Co Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Operating Margin % falls into.


SHSE:600566
86GF Score
Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hubei Jumpcan Pharmaceutical Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Hubei Jumpcan Pharmaceutical Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=1877.225 / 6218.642
=30.19 %

Hubei Jumpcan Pharmaceutical Co's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=340.138 / 1207.499
=28.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 28.17% mean?
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) has a Operating Margin % of 28.17% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. This is near median its historical median of 25.91. Over the past decade, Hubei Jumpcan Pharmaceutical Co's Operating Margin % has ranged from 22.15 to 30.89. According to the industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #51 out of 952 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is Hubei Jumpcan Pharmaceutical Co's Operating Margin % too high?
Hubei Jumpcan Pharmaceutical Co's current Operating Margin % of 28.17% is near median its 10-year median of 25.91. Over the past 10 years, this metric has ranged from a low of 22.15 to a high of 30.89. The Drug Manufacturers industry median Operating Margin % is 7.58. Hubei Jumpcan Pharmaceutical Co's value of 28.17% is 271.6% above this industry median. Based on the distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #51 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hubei Jumpcan Pharmaceutical Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hubei Jumpcan Pharmaceutical Co's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hubei Jumpcan Pharmaceutical Co ranks #51 out of 952 companies for Operating Margin %. This places Hubei Jumpcan Pharmaceutical Co in the top 5% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.58. Hubei Jumpcan Pharmaceutical Co's value of 28.17% is 271.6% above this benchmark. Historically, Hubei Jumpcan Pharmaceutical Co's own Operating Margin % has ranged from 22.15 to 30.89 over the past decade. While the company's 10-year median is 25.91 vs. the industry median of 7.58, Hubei Jumpcan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hubei Jumpcan Pharmaceutical Co's current Operating Margin % of 28.17% is 271.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Jumpcan Pharmaceutical Co's current Operating Margin % is 28.17%, which is near median its own 10-year median of 25.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Jumpcan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co (SHSE:600566) is currently considered Fairly Valued. The stock's GF Value™ is ¥20.89, compared to a current price of ¥21.66 — trading 3.7% above its estimated fair value. The current Operating Margin % is 28.17%, which is near median its 10-year median of 25.91 and 271.6% above the Drug Manufacturers industry median of 7.58. Hubei Jumpcan Pharmaceutical Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Hubei Jumpcan Pharmaceutical Co (SHSE:600566), the current Operating Margin % is 28.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?

Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥21.66 is trading 3.7% above its estimated GF Value™ of ¥20.89. GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600566:

  • Operating Margin %: 28.17% (near median its 10-year median of 25.91)
  • GF Value™: ¥20.89 vs. price of ¥21.66 (3.7% above fair value)
  • GF Score™: 86/100 with 3 warning signs
  • Industry Position: 271.6% above the Drug Manufacturers median (#51 of 952)

No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hubei Jumpcan Pharmaceutical Co Business Description

Address Daqing West Road, Baota Bay, Jiangsu Province, Taixing, CHN, 225441
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
86GF Score

Get the complete analysis for SHSE:600566

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.66
Price
¥20.89
GF Value